Table of Contents
Trends in risk assessment
Potential utility of biomarkers to discovery and development of new pharmaceuticals
Potential utility of biomarkers to risk assessment
A conceptual view of biomarkers
Source of materials and methodologies for assessment of biomarkers
Biomarkers of hazard: specific examples
Products of altered gene and protein expression
Biomarkers: extrapolation between animals and man
Biomarkers: cross species extrapolation
PPT Slide
Biomarkers: cross species extrapolation for risk assessment
Biomarkers: application to risk assessment
Biomarkers: application to risk assessment
Biomarkers of effects induced by Thiazolidinediones
Plasma von Willebrand factor rats given 60 mg/kg SKF-82526
Heart weight in different models of cardiac hypertrophy
LV-cTnT concentration in difference models of cardiac hypertrophy
|